Vanguard Capital Management’s Palisade Bio PALI Stock Holding History
Bought
Maintained
Sold
Other funds holding PALI
BGI
Vanguard Capital Management's PALI Position: Q3 2026 in Review
Vanguard Capital Management increased its Palisade Bio (PALI) stake by 358% in Q3 2026, buying an estimated $12M and bringing the position to 7,888,020 shares worth $10.6M. The position accounts for ﹤0.01% of the portfolio, ranked #2719.
Vanguard Capital Management first reported a position in PALI in Q1 2026 and has held it in 3 quarters since. 114 funds tracked by Wall St. Rank hold PALI as of Q3 2026.
- Vanguard Capital Management held 7,888,020 shares of Palisade Bio worth $10.6M as of Q3 2026.
- Vanguard Capital Management bought 6,165,203 Palisade Bio shares in Q3 2026, an estimated $12M.
- Palisade Bio made up ﹤0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #2719 holding.
- Vanguard Capital Management first reported a position in Palisade Bio in Q1 2026 and has held it in 3 quarters since.
- 114 funds tracked by Wall St. Rank held Palisade Bio as of Q3 2026.
Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.